The apparent contradiction between the elevated circulating FGF21 in obese patients in a previous study [33] and the finding of sarcopenia in the present study may be an interesting mechanistic link between chronic metabolic conditions and muscle loss. The gene discussed is FGF21; the disease is sarcopenia.